This topic contains a solution. Click here to go to the answer

Author Question: To convey an experience or idea, we translate, or ___________, that experience into symbols. We use ... (Read 50 times)

jenna1

  • Hero Member
  • *****
  • Posts: 568
To convey an experience or idea, we translate, or ___________, that experience into symbols. We use words or other verbal behaviors or nonverbal behaviors such as gestures to convey the experience or idea .
 
  Fill in the blanks with correct word

Question 2

In certain situations, a rationale for discriminating on the basis of a business necessity is referred to as
 
  a. Pro bono hiring (PBH).
  b. Bona fide qualified employee (BFQE).
  c. Bona fide occupational qualifier (BFOQ).
  d. Per se qualifiers (PSQ).



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Alyson.hiatt@yahoo.com

  • Sr. Member
  • ****
  • Posts: 354
Answer to Question 1

encode

Answer to Question 2

c





 

Did you know?

Common abbreviations that cause medication errors include U (unit), mg (milligram), QD (every day), SC (subcutaneous), TIW (three times per week), D/C (discharge or discontinue), HS (at bedtime or "hours of sleep"), cc (cubic centimeters), and AU (each ear).

Did you know?

All patients with hyperparathyroidism will develop osteoporosis. The parathyroid glands maintain blood calcium within the normal range. All patients with this disease will continue to lose calcium from their bones every day, and there is no way to prevent the development of osteoporosis as a result.

Did you know?

The human body produces and destroys 15 million blood cells every second.

Did you know?

ACTH levels are normally highest in the early morning (between 6 and 8 A.M.) and lowest in the evening (between 6 and 11 P.M.). Therefore, a doctor who suspects abnormal levels looks for low ACTH in the morning and high ACTH in the evening.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library